US relents, says it will support patent waivers on Covid-19 vaccines
US relents, says it will support patent waivers on Covid-19 vaccines
Declaring that "extraordinary times and circumstances of call for extraordinary measures," the United States on Tuesday announced it will support waiver of intellectual property protection on Covid-19 vaccines to help end the coronavirus pandemic.
Declaring that "extraordinary times and circumstances of call for extraordinary measures," the United States on Tuesday announced it will support waiver of intellectual property protection on Covid-19 vaccines to help end the coronavirus pandemic.